Naftzger J. Christopher

Insider profile

Naftzger J. Christopher's trades of Arbutus Biopharma Corp's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-05 2025-02-04 PlS Planned sale
61,704 -21.2%
11.77
US$4,433,882
61,704 -21.2% 11.77 US$4,433,882
2025-02-04 2025-02-04 PrS Proposed sale
10,642
492.14
US$138,827
10,642 492.14 US$138,827